ATLANTIC AMERICAN CORP FY 2025: Revenue $210.4M, EPS $0.28— 10-K Summary

Atlantic American Corp reported FY 2025 revenue of $210.4M, up 11.9% YoY, and net income of $6.02M, reversing a prior-year loss. EPS was $0.28, driven by underwriting improvements, higher premiums, and investment gains. The company also disclosed a material weakness in premium receivable controls and restated 2024 figures.

Original reporting
Published Oct 16, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ATLANTIC AMERICAN CORP FY 2025: Revenue $210.4M, EPS $0.28— 10-K Summary — source image
Decision brief

The 30-second read

$AAMEBullishMed
01

Why it matters

The earnings beat could attract short‑term buying interest and a modest price rally.

02

Market read

Micro‑cap insurance stock with a fresh profit report, offering a potential short‑term upside.

03

What to watch

Net investment income and unrealized gains contributed to profitability, which may be less sustainable.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

Atlantic American Corp filed its FY2025 10‑K, showing a turnaround to profitability after a loss in 2024.

Company-level read

Ticker impact

$AAMEBullishHigh confidence
Context

Atlantic American Corp posted FY2025 revenue of $210.4M and EPS of $0.28, reversing a loss and showing profitability for the first time.

Expected impact

likely upward pressure as the market prices in the earnings beat and profit reversal

Evidence & confidence

The company reported a profit after a prior loss, driven by higher premiums and investment gains, which is a material positive catalyst.

Market effects

Improved underwriting performance may signal strength in the P&C and Medicare Supplement segments.

Limited to U.S. insurance sector investors.

Low, as the company is a micro‑cap with niche exposure.

Counterpoint

The material weakness in premium receivable controls could pose future risk despite the earnings beat.

Key entities

  • Atlantic American Corp

    U.S. property & casualty insurer reporting FY2025 results.

Related articles

$PTHSMed

Pelthos (PTHS) Q3 2026 Earnings Call Transcript

Pelthos (PTHS) reported Q3 2026 net revenue of $15.2M, up 114% YoY, with Zelsuvmi treating 31,000 patients. Formulary coverage expanded to 70% of commercial lives. The company announced a deal with Castle Creek Biosciences, aiming to leverage synergies in dermatology and cell/gene therapy markets. Xepi and Xeglyze launches are planned for 2027.

$BMNRMedAI 8/10

Bitmine’s ($BMNR) $6.3 Billion Loss Highlights Overall Risks for Strategy ($MSTR) and Other Treasury Firms as MSCI Tightens Rules

Bitmine Immersion Technologies (BMNR) reported a $6.3B net loss for fiscal 2026, driven by $6.23B in unrealized losses on digital-asset holdings, primarily ether. The company held 5.9M ether tokens and 211 bitcoin at year-end. Operating revenue was $125M, with staking contributing 97%. MSCI's updated index rules may impact BMNR and other crypto-focused treasury firms, including Strategy (MSTR).

HighAI 8/10

Merck KGaA Earnings Call Signals Stronger Growth Ahead

Merck KGaA (MKKGY) reported Q3 earnings with accelerated growth, raised full-year guidance, and announced strategic investments. Key highlights include 5.1% organic sales growth, EUR 1.66B operating cash flow, and plans to acquire Silence Therapeutics. Management emphasized growth in biomanufacturing, semiconductors, and rare diseases, while noting Mavenclad's declining sales and softer demand in consumer electronics.

$EZPWMed

EZCORP shares fall despite record Q4 as costs overshadow beat

EZCORP (EZPW) reported Q4 revenue of $447M, beating estimates, with full-year revenue up 30% to $1.7B and adjusted EBITDA up 47% to $277M. Despite strong results, shares fell 4.13% due to concerns about labor costs and integration timing in Latin America. Insiders filed SEC disclosures, and short-sale activity increased ahead of the earnings release.

$FLNTMed

What Fluent (FLNT) Said on Its Q3 Earnings Call

Fluent (FLNT) reported a Q3 net loss of $3.1M, improved from last year. Adjusted EBITDA loss narrowed to $43K, with positive EBITDA expected in Q4. Cash decreased to $11.4M, with $31.5M in short-term debt. The company guided toward high 20% gross margins and potential double-digit revenue growth in 2027, while testing in-store and loyalty offerings.